|
1
|
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
|
J Clin Oncol
|
1992
|
1.55
|
|
2
|
The National Cancer Data Base report on gastric carcinoma.
|
Cancer
|
1997
|
1.23
|
|
3
|
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.
|
Int J Radiat Oncol Biol Phys
|
1996
|
1.14
|
|
4
|
Squamous cell carcinoma of the breast: a clinical approach.
|
Ann Surg Oncol
|
1996
|
1.11
|
|
5
|
Haematological effects of aspirin.
|
Lancet
|
1972
|
1.04
|
|
6
|
Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
|
Breast Cancer Res Treat
|
1982
|
1.02
|
|
7
|
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
|
J Clin Oncol
|
1993
|
0.94
|
|
8
|
Interobserver variation in the identification of breast carcinoma in intramammary lymphatics.
|
Hum Pathol
|
1982
|
0.93
|
|
9
|
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
|
J Clin Oncol
|
1992
|
0.92
|
|
10
|
Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor.
|
Cancer
|
1983
|
0.88
|
|
11
|
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.
|
Cancer Treat Rep
|
1976
|
0.87
|
|
12
|
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
|
Surgery
|
1984
|
0.85
|
|
13
|
Trace elements that act to inhibit neoplastic growth.
|
Ann N Y Acad Sci
|
1972
|
0.82
|
|
14
|
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.
|
Cancer
|
1994
|
0.81
|
|
15
|
Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
|
Cancer Treat Rep
|
1976
|
0.79
|
|
16
|
Plasma-zinc concentration in patients with bronchogenic cancer.
|
Lancet
|
1972
|
0.78
|
|
17
|
Comparison of the membrane-related effects of cytarabine and other agents on model membranes.
|
Biochem Pharmacol
|
1985
|
0.77
|
|
18
|
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trial.
|
Breast Cancer Res Treat
|
1981
|
0.77
|
|
19
|
The efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel preparation for elective colonic surgery: a randomized, prospective, blinded clinical trial.
|
Surgery
|
1985
|
0.77
|
|
20
|
Endoscopic laser therapy for obstructing and/or bleeding colorectal carcinoma.
|
Am Surg
|
1992
|
0.77
|
|
21
|
A long-term analysis of 620 patients with malignant melanoma at a major referral center.
|
Surgery
|
1998
|
0.76
|
|
22
|
Implications of the inhibition of animal tumors by dietary zinc deficiency.
|
Adv Exp Med Biol
|
1977
|
0.76
|
|
23
|
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial.
|
Cancer
|
1980
|
0.76
|
|
24
|
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
|
Eur J Cancer
|
1980
|
0.75
|
|
25
|
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancer.
|
Surgery
|
1990
|
0.75
|
|
26
|
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year results.
|
Breast Cancer Res Treat
|
1983
|
0.75
|
|
27
|
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).
|
J Natl Cancer Inst Monogr
|
1992
|
0.75
|
|
28
|
The value of prognostic factors in selecting node-negative breast cancer patients for adjuvant therapy.
|
J Surg Oncol
|
1992
|
0.75
|
|
29
|
The role of pre-resectional laser recanalization for obstructing carcinomas of the colon and rectum.
|
Surgery
|
1989
|
0.75
|
|
30
|
Trace element profiles in cancer patients.
|
Biol Trace Elem Res
|
1979
|
0.75
|
|
31
|
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agents.
|
Cancer Treat Rep
|
1987
|
0.75
|
|
32
|
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
|
Am J Clin Oncol
|
1995
|
0.75
|
|
33
|
Percutaneous long-term hepatic artery infusion for primary and metastatic cancer in the liver.
|
R I Med J
|
1975
|
0.75
|
|
34
|
The prognostic importance of estrogen receptor level for Stage I breast cancer patients.
|
Curr Surg
|
1984
|
0.75
|
|
35
|
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report.
|
Surgery
|
1980
|
0.75
|
|
36
|
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
|
Cancer
|
2001
|
0.75
|
|
37
|
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
|
Blood
|
1991
|
0.75
|